Alexion Pharmaceuticals, Inc. Share | Buy US Stock from India on Kuvera

Q: Can I buy Alexion Pharmaceuticals, Inc. shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Alexion Pharmaceuticals, Inc. stocks after a simple registration process. </div>

Q: How to buy Alexion Pharmaceuticals, Inc. shares in India?

<div> To buy Alexion Pharmaceuticals, Inc. shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Alexion Pharmaceuticals, Inc. and you are done!</div> </div>

Q: What is the share price of Alexion Pharmaceuticals, Inc.?

<div>The share price of Alexion Pharmaceuticals, Inc. is USD 182.5 as on 21 Jul.</div>

Q: What is the Market Capitalization of Alexion Pharmaceuticals, Inc.?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Alexion Pharmaceuticals, Inc. is USD 40.46B as on 21 Jul.</div>

Q: What is the PE ratio of Alexion Pharmaceuticals, Inc.?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Alexion Pharmaceuticals, Inc. is 59.91 as on 21 Jul. </div>

Q: Is Alexion Pharmaceuticals, Inc. a good stock to buy?

<div>Kuvera provides relevant fundamental details of Alexion Pharmaceuticals, Inc. to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Alexion Pharmaceuticals, Inc. operate?

<div> Alexion Pharmaceuticals, Inc. operates in Healthcare / Biotechnology

Healthcare Biotechnology

$182.5

(21 Jul)

Loading Chart

Previous close

$182.50

Open

$182.50

Today’s high

$182.67

Today’s low

$180.13

52W low

$99.91

52W high

$187.45

13.91%

Volume

59.91

EPS (TTM)

3.05

Shares O/S

220.47M

Market cap

40.46B

Insights

ALXN has made a new 52 Wk high. 52 Wk high stocks tend to outperform in the near term.

ALXN price is above its 200 day moving average

ALXN PE is in the top end of its range over the past 2 years

ALXN PE is in the highest 10% across all stocks. The market is valuing it as a growth stock on an earnings basis.

In beta. Send feedback here.

Compare with other stock

About Alexion Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Company’s marketed products include SOLIRIS (eculizumab), Strensiq (asfotase alfa), Kanuma (sebelipase alfa), ULTOMIRIS, Andexxa and Ondexxya. The Company’s clinical development programs include ALXN1210, ALXN1810, ALXN1720, ALXN1830, ALXN1840 and ABY-039.

The Company’s ULTOMIRIS is a long-acting C5 inhibitor discovered and developed by Alexion that works by inhibiting the C5 protein in the terminal complement cascade. Its SOLIRIS is an C5 inhibitor discovered and developed by Alexion that works by inhibiting the C5 protein in the terminal complement cascade. SOLIRIS is a humanized monoclonal antibody that effectively blocks terminal complement activity at the doses prescribed. .

FAQs

Can I buy Alexion Pharmaceuticals, Inc. shares in India?

How to buy Alexion Pharmaceuticals, Inc. shares in India?

What is the share price of Alexion Pharmaceuticals, Inc.?

What is the Market Capitalization of Alexion Pharmaceuticals, Inc.?

What is the PE ratio of Alexion Pharmaceuticals, Inc.?

Is Alexion Pharmaceuticals, Inc. a good stock to buy?

In which sector / industry does Alexion Pharmaceuticals, Inc. operate?